Literature DB >> 9183817

Amphetamine increases the phosphorylation of neuromodulin and synapsin I in rat striatal synaptosomes.

S Iwata1, G H Hewlett, M E Gnegy.   

Abstract

Amphetamine is taken up through the dopamine transporter in nerve terminals and enhances the release of dopamine. We previously found that incubation of rat striatal synaptosomes increases phosphorylation of the presynaptic neural-specific protein, neuromodulin (Gnegy et al., Mol. Brain Res. 20:289-293, 1993). Using a state-specific antibody, we now demonstrate that incubation of rat striatal synaptosomes with amphetamine increases levels of neuromodulin phosphorylated at ser41, the protein kinase C substrate site. Phosphorylation was maximal at 5 min at 37 degrees C at concentrations from 100 nM to 10 microM amphetamine. The effect of amphetamine on the phosphorylation of synapsin I at a site specifically phosphorylated by Ca2+/calmodulin-dependent protein kinase II (site 3), was examined using a state-specific antibody for site 3-phosphosynapsin I. Incubation with concentrations of amphetamine from 1 to 100 nM increased the level of site 3-phospho-synapsin I at times from 30 sec to 2 min. The effect of amphetamine on synapsin I phosphorylation was blocked by nomifensine. The presence of calcium in the incubating buffer was required for amphetamine to increase the level of site 3-phospho-synapsin I. The amphetamine-mediated increase in the content of phosphoser41-neuromodulin was less sensitive to extrasynaptosomal calcium. The amphetamine-mediated increase in the content of site 3-phospho-synapsin I persisted in the presence of 10 microM okadaic acid and was not significantly altered by D1 or D2 dopamine receptor antagonists. Preincubation of striatal synaptosomes with 10 microM of the protein kinase C inhibitor, Ro-31-8220, blocked the amphetamine-mediated increases in the levels of both phosphoser41-neuromodulin and site 3-phospho-synapsin I. Our results demonstrate that amphetamine can alter phosphorylation-related second messenger activities in the synaptosome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9183817     DOI: 10.1002/(SICI)1098-2396(199707)26:3<281::AID-SYN9>3.0.CO;2-3

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  13 in total

Review 1.  Tamoxifen and amphetamine abuse: Are there therapeutic possibilities?

Authors:  Sarah Mikelman; Natalie Mardirossian; Margaret E Gnegy
Journal:  J Chem Neuroanat       Date:  2016-08-30       Impact factor: 3.052

Review 2.  Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics.

Authors:  Rosilla F Bachmann; Robert J Schloesser; Todd D Gould; Husseini K Manji
Journal:  Mol Neurobiol       Date:  2005-10       Impact factor: 5.590

3.  Mood stabilizer psychopharmacology.

Authors:  Todd D Gould; Guang Chen; Husseini K Manji
Journal:  Clin Neurosci Res       Date:  2002-11-14

4.  Dopamine transporter trafficking: rapid response on demand.

Authors:  Rong Chen; Cheryse A Furman; Margaret E Gnegy
Journal:  Future Neurol       Date:  2010-01-01

5.  Amphiphysin I but not dynamin I nor synaptojanin mRNA expression increased after repeated methamphetamine administration in the rat cerebrum and cerebellum.

Authors:  Mitsuko Hamamura; Jiro Okouchi; Hidetoshi Ozawa; Yoshihiko Kimuro; Akiko Iwaki; Yasuyuki Fukumaki
Journal:  J Neural Transm (Vienna)       Date:  2012-12-08       Impact factor: 3.575

6.  Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania.

Authors:  Steven T Szabo; Rodrigo Machado-Vieira; Peixiong Yuan; Yun Wang; Yanling Wei; Cynthia Falke; Chiara Cirelli; Giulio Tononi; Husseini K Manji; Jing Du
Journal:  Neuropharmacology       Date:  2008-08-22       Impact factor: 5.250

7.  Beta2-containing nicotinic acetylcholine receptors mediate calcium/calmodulin-dependent protein kinase-II and synapsin I protein levels in the nucleus accumbens after nicotine withdrawal in mice.

Authors:  Kia J Jackson; M Imad Damaj
Journal:  Eur J Pharmacol       Date:  2013-01-10       Impact factor: 4.432

8.  PKCβ Inhibitors Attenuate Amphetamine-Stimulated Dopamine Efflux.

Authors:  Alexander G Zestos; Sarah R Mikelman; Robert T Kennedy; Margaret E Gnegy
Journal:  ACS Chem Neurosci       Date:  2016-03-28       Impact factor: 4.418

9.  Beta 2 subunit-containing nicotinic receptors mediate acute nicotine-induced activation of calcium/calmodulin-dependent protein kinase II-dependent pathways in vivo.

Authors:  K J Jackson; C L Walters; M I Damaj
Journal:  J Pharmacol Exp Ther       Date:  2009-05-12       Impact factor: 4.030

10.  The PKC inhibitor Ro31-8220 blocks acute amphetamine-induced dopamine overflow in the nucleus accumbens.

Authors:  Jessica A Loweth; Robyn Svoboda; Jennifer D Austin; Anitra M Guillory; Paul Vezina
Journal:  Neurosci Lett       Date:  2009-03-11       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.